SNDX
Syndax Pharmaceuticals, Inc.
16.65
USD
This page is just a preview of the data found in TrendSpider’s full version
Syndax Pharmaceuticals, Inc. stock is up 22.88% since 30 days ago. The next earnings date is Feb 27, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 7 December’s closed higher than November. In the last 6 Unusual Options Trades, there were 2 PUTs, 4 CALLs.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 23 Oct 18:45 | 17 Nov, 2023 | 12.50 | 1884 | ||
| 30 Oct 14:42 | 19 Jan, 2024 | 17.50 | 116 | ||
| 02 Nov 19:27 | 17 Nov, 2023 | 15.00 | 521 | ||
| 03 Nov 13:45 | 17 Nov, 2023 | 15.00 | 2237 | ||
| 16 Nov 15:16 | 19 Jan, 2024 | 12.50 | 20 | ||
| 16 Nov 15:16 | 19 Jan, 2024 | 20.00 | 4453 |
Syndax Pharmaceuticals, Inc. develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein.
